PRNewswire/ - MolecuLight Corp., a global pioneer in point-of-care fluorescence imaging for wound care, is proud to showcase ...

a global pioneer in point-of-care fluorescence imaging for wound care, is proud to showcase its presence at the St. Louis Wound & Vascular Symposium, being held today, Saturday, June 21 ...

On Philadelphia’s North Broad Street, Dr. Jon George, along with his business partner, Dr. Vincent Varghese, is introducing sophisticated interventional cardiology technology that he says could change ...

Finnish startup AIATELLA has raised €2m ($2.27m) in financing to develop and scale its cardiovascular imaging technology ...

SAN JOSE, Calif.--(BUSINESS WIRE)--Evident Vascular, Inc., a medical technology company developing a best-in-class intravascular ultrasound (IVUS) platform powered by artificial intelligence ...

Funding to accelerate development of next-generation intravascular ultrasound platform and support FDA clearance for U.S. market launch Evident Vascular, Inc., a medical technology company ...

The 26th annual New Cardiovascular Horizons (NCVH) conference brought 1,400 from across the globe to New Orleans to ...

MolecuLight Corp., a global pioneer in point-of-care fluorescence imaging for rapid detection of infection causing bacteria in wounds, is pleased to announce its participation in the Society for ...

In the fast-evolving world of modern endovascular surgery, precision and efficiency in surgical procedures are crucial. Ziehm ...

A study reveals significant retinal vessel changes in diabetic retinopathy, highlighting the need for early detection methods ...

Finland: Medtech startup AIATELLA has secured €2 million in funding to accelerate the development and scaling of its ...